<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04821492</url>
  </required_header>
  <id_info>
    <org_study_id>FSD-HCY-2020-05</org_study_id>
    <nct_id>NCT04821492</nct_id>
  </id_info>
  <brief_title>Relationship Between Homocysteine and BMD</brief_title>
  <official_title>Evaluation of the Relationship Between Homocysteine Levels and Bone Mineral Density in Postmenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Santiago Dexeus Font</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Universitari Dexeus</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The association between Homocysteine (Hcy) levels and bone mineral density (BMD) has been&#xD;
      debated. Some studies have found a relationship between increased Hcy plasma levels and BMD&#xD;
      in contrast; other studies have not found a relationship. The purpose of our study was to&#xD;
      investigate whether or not Hcy plasma levels are related to BMD in a group of postmenopausal&#xD;
      women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BMD expressed in absolute values as g/cm2</measure>
    <time_frame>one year before or after Homocysteine levels</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Lumbar spine T-score</measure>
    <time_frame>one year before or after Homocysteine levels</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Femoral neck T-score</measure>
    <time_frame>one year before or after Homocysteine levels</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total hip T-score</measure>
    <time_frame>one year before or after Homocysteine levels</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">760</enrollment>
  <condition>Postmenopausal Women</condition>
  <arm_group>
    <arm_group_label>Hyperhomocysteinemia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Hcy levels</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dual-Energy X-ray Absorptiometry (DXA)</intervention_name>
    <description>BMD expressed in absolute values as g/cm2 and T-scores</description>
    <arm_group_label>Hyperhomocysteinemia</arm_group_label>
    <arm_group_label>Normal Hcy levels</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women visited at the Obstetrics and Gynecology Department at the Hospital Universitario&#xD;
        Dexeus (Barcelona, Spain).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Postmenopausal women&#xD;
&#xD;
          -  BMD measured by dual-energy X-ray absorptiometry (DXA)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary ovarian failure&#xD;
&#xD;
          -  Early menopause&#xD;
&#xD;
          -  Cardiovascular, liver, or renal diseases&#xD;
&#xD;
          -  Surgical menopause&#xD;
&#xD;
          -  History of cancer&#xD;
&#xD;
          -  Receiving treatment known to influence levels of Hcy or bone mineralization (folates&#xD;
             or vitamin B12 supplements, menopausal hormonal treatment, corticosteroids,&#xD;
             anticonvulsants, heparin, thiazide diuretics, and antiresorptive agents).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario Quiron Dexeus</name>
      <address>
        <city>Barcelona</city>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://dexeus.com</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Cagnacci A, Bagni B, Zini A, Cannoletta M, Generali M, Volpe A. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone. 2008 Feb;42(2):314-20. doi: 10.1016/j.bone.2007.10.022. Epub 2007 Nov 12.</citation>
    <PMID>18289506</PMID>
  </reference>
  <reference>
    <citation>Mittal M, Verma R, Mishra A, Singh A, Kumar V, Sawlani KK, Ahmad MK, Mishra P, Gaur R. Relation of Bone Mineral Density with Homocysteine and Cathepsin K levels in Postmenopausal Women. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):261-266. doi: 10.4103/ijem.IJEM_575_17.</citation>
    <PMID>29911042</PMID>
  </reference>
  <reference>
    <citation>Enneman AW, Swart KM, Zillikens MC, van Dijk SC, van Wijngaarden JP, Brouwer-Brolsma EM, Dhonukshe-Rutten RA, Hofman A, Rivadeneira F, van der Cammen TJ, Lips P, de Groot CP, Uitterlinden AG, van Meurs JB, van Schoor NM, van der Velde N. The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons. Bone. 2014 Jun;63:141-6. doi: 10.1016/j.bone.2014.03.002. Epub 2014 Mar 12.</citation>
    <PMID>24631997</PMID>
  </reference>
  <reference>
    <citation>Bahtiri E, Islami H, Rexhepi S, Qorraj-Bytyqi H, Thaçi K, Thaçi S, Karakulak C, Hoxha R. Relationship of homocysteine levels with lumbar spine and femur neck BMD in postmenopausal women. Acta Reumatol Port. 2015 Oct-Dec;40(4):355-62. Review.</citation>
    <PMID>26922199</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 24, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut Universitari Dexeus</investigator_affiliation>
    <investigator_full_name>Pascual García</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

